Tracking autism: ‘Recalibrated’ test may better reflect progression over time

autism spectrum disorder managing behaviour
Credit: Raising Children

A recalibrated version of a widely used test for autism may accurately reflect autistic children’s development as they grow and become verbal, according to a new study. The revised test identifies worsening autism traits in a subgroup of children who would not otherwise have been flagged for the condition. The Autism Diagnostic Observation Schedule (ADOS) is one of the standard tests for autism.

But ADOS scores are not consistent across these modules because of, for example, the natural development of language. This mismatch may prevent doctors from accurately tracking children over time and cause them to miss opportunities for intervention, says So Hyun Kim.

Instead of using the raw ADOS scores, Kim’s team used a statistically calibrated version called Calibrated Severity Scores (CSS). This scale measures autism severity independent of characteristics that change over time, such as language and cognition; it provides standard scores from 1 to 10 for core autism features at each age and language level.

“When comparing children from one time point to another point, we are more sure the changes are not driven by changes in aging or language, but by the underlying autism,” Kim says. “It can allow more valid comparisons across modules.”

Read full, original post: Revised test offers reliable way to track autism over time

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.